Identification of B- and T-Cell Epitopes within the Fibronectin-Binding Domain of the SfbI protein of Streptococcus pyogenes

Infection and Immunity

Volumn 71, Issue 12, 2003, Pages 7197-7201

  Schulze, Kai ^a   Medina, Eva ^a   Chhatwal, Gursharan S ^a   Guzmán, Carlos A ^a  

^a HELMHOLTZ CENTRE FOR INFECTION RESEARCH   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACID; BACTERIAL PROTEIN; EPITOPE; FIBRONECTIN; POLYPEPTIDE; PROTEIN SFBI; UNCLASSIFIED DRUG;

AMINO ACID ANALYSIS; AMINO ACID SEQUENCE; ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; B LYMPHOCYTE; BACTERIAL VIRULENCE; BINDING AFFINITY; CONGENIC STRAIN; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; HAPLOTYPE; HUMORAL IMMUNITY; IMMUNE RESPONSE; IMMUNIZATION; MOLECULAR RECOGNITION; MOUSE; MOUSE STRAIN; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BINDING; PROTEIN DOMAIN; SEQUENCE ANALYSIS; STREPTOCOCCUS PYOGENES; T LYMPHOCYTE;

ADHESINS, BACTERIAL; ADMINISTRATION, INTRANASAL; AMINO ACID SEQUENCE; ANIMALS; BACTERIAL PROTEINS; CARRIER PROTEINS; EPITOPE MAPPING; EPITOPES, B-LYMPHOCYTE; EPITOPES, T-LYMPHOCYTE; FIBRONECTINS; IMMUNIZATION; IMMUNOBLOTTING; MICE; MICE, CONGENIC; MICE, INBRED BALB C; MOLECULAR SEQUENCE DATA; PEPTIDES; STREPTOCOCCAL INFECTIONS; STREPTOCOCCAL VACCINES; STREPTOCOCCUS PYOGENES;

EID: 0344851599     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/IAI.71.12.7197-7201.2003     Document Type: Article

References (32)

1. Ada, G., and A. Ramsay. 1996. Vaccines, vaccination and the immune response, p. 138-141. Lippincott-Raven, Philadelphia, Pa.
2. Bessen, D., and V. A. Fischetti. 1988. Influence of intranasal immunization with synthetic peptides corresponding to conserved epitopes of M protein on mucosal colonization by group A streptococci Infect. Immun. 56:2666-2672.
3. Bisno, A. L. 1991. Group A streptococcal infections and acute rheumatic fever. N. Engl. J. Med. 325:783-793.
4. Brandt, E. R., W. A. Hayman, B. Currie, J. Carapetis, D. C. Jackson, K.-A. Do, and M. F. Good. 1999. Functional analysis of IgA antibodies specific for a conserved epitope within the M protein of group A streptococci from Australian aboriginal endemic communities. Int. Immunol. 11:569-576.
5. Brandt, E. R., T. Teh, W. A. Relf, R. I. Hobb, and M. F. Good. 2000. Protective and nonprotective epitopes from amino termini of M proteins from Australian aboriginal isolates and reference strains of group A streptococci. Infect. Immun. 68:6587-6594.
6. Brandt, E. R., K. S. Sriprakash, R. I. Hobb, W. A. Hayman, W. Zeng, M. R. Batzloff, D. C. Jackson, and M. F. Good. 2000. New multi-determinant strategy for a group A streptococcal vaccine designed for the Australian Aboriginal population. Nat. Med. 6:455-459.
7. Cornaglia, G., M. Ligozzi, A. Mazzariol, M. Valentini, G. Orefici, R. Fontana, et al. 1996. Rapid increase of resistance to erythromycin and clindamycin in Streptococcus pyogenes in Italy, 1993-1995. Emerg. Infect. Dis. 2:339-342.
8. Frank, R. 1992. Spot-synthesis: an easy technique for the positionally addressable, parallel chemical synthesis on a membrane support. Tetrahedron 48:9217-9232.
9. Guzmán, C. A., S. R. Talay, G. Molinari, E. Medina, and G. S. Chhatwal. 1999. Protective immune response against Streptococcus pyogenes in mice after intranasal vaccination with the fibronectin-binding protein SfbI. J. Infect. Dis. 179:901-906.
10. Ji, Y., B. Carlson, A. Kondagunta, and P. P. Cleary. 1997. Intranasal immunization with C5a peptidase prevents nasopharyngeal colonization of mice by the group A Streptococcus. Infect. Immun. 65:2080-2087.
11. Johnson, D. R., D. L. Stevens, and E. L. Kaplan. 1992. Epidemiologic analysis of group A streptococcal serotypes associated with severe systemic infections, rheumatic fever, or uncomplicated pharyngitis. J. Infect. Dis. 166:374-382.
12. Kapur, V., J. T. Maffei, R. S. Greer, L. L. Li, G. J. Adams, and J. M. Musser. 1994. Vaccination with streptococcal extracellular cysteine protease (interleukin-lβ convertase) protects mice against challenge with heterologous group A streptococci. Microb. Pathog. 16:443-450.
13. LaPenta, D., C. Rubens, E. Chi, and P. P. Cleary. 1994. Group A streptococci efficiently invade human respiratory epithelial cells. Proc. Natl. Acad. Sci. USA 91:12115-12119.
14. Medina, E., S. R. Talay, G. S. Chhatwal, and C. A. Guzman. 1998. Fibronectin-binding protein I of Streptococcuspyogenes promotes T cell-independent proliferation of murine B lymphocytes and enhances the expression of MHC class II molecules on antigen-presenting cells. Int. Immunol. 10:1657-1664.
15. Medina, E., S. R. Talay, G. S. Chhatwal, and C. A. Guzmán. 1998. Fibronectin-binding protein I of Streptococcus pyogenes is a promising adjuvant for antigens delivered by mucosal route. Eur. J. Immunol. 28:1069-1077.
16. Molinari, G., S. R. Talay, P. Valentin Weigand, M. Rohde, and G. S. Chhatwal. 1997. The fibronectin-binding protein of Streptococcus pyogenes, SfbI, is involved in the internalization of group A streptococci by epithelial cells. Infect. Immun. 65:1357-1363.
17. Nardin, E. H., G. A. Oliveira, J. M. Calvo-Calle, and R. Nussenzweig. 1995. The use of multiple antigen peptides in the analysis and induction of protective immune responses against infectious diseases. Adv. Immunol. 50:105-150.
18. Neu, H. C. 1992. The crisis in antibiotic resistance. Science 257:1064-1073.
19. Olsen, A. W., P. R. Hansen, A. Holm, and P. Andersen. 2000. Efficient protection against Mycobacterium tuberculosis by vaccination with a single subdominant epitope from the ESAT-6 antigen. Eur. J. Immunol. 30:1724-1732.
20. Pruksakorn, S., A. Galbraith, R. A. Houghten, and M. F. Good. 1992. Conserved T and B cell epitopes on the M protein of group A streptococci. Induction of bactericidal antibodies. J. Immunol. 149:2729-2735.
21. Rammensee, H., J. Bachmann, N. P. Emmerich, O. A. Bachor, and S. Stevanovic. 1999. SYFPEITHI: database for MHC ligands and peptide motifs. Immunogenetics 50:213-219.
22. Schulze, K., E. Medina, S. R. Talay, R. J. Towers, G. S. Chhatwal, and C. A. Guzmán. 2001. Characterization of the domain of fibronectin-binding protein I of Streptococcus pyogenes responsible for elicitation of a protective immune response, Infect. Immun. 69:622-625.
23. Schulze, K., and C. A. Guzmán. 2003. Identification of the domains of the fibronectin-binding protein I of Streptococcus pyogenes responsible for adjuvanticity. FEMS Immunol. Med. Microbiol. 37:173-177.
24. + T cell responses. J. Immunol. 166:1106-1113.
25. Stevens, D. L. 1995. Streptococcal toxic-shock syndrome: spectrum of disease, pathogenesis, and new concepts in treatment. Emerg. Infect. Dis. 1:69-78.
26. Talay, S. R., P. Valentin Weigand, P. G. Jerlstrom, K. N. Timmis, and G. S. Chhatwal. 1992. Fibronectin-binding protein of Streptococcus pyogenes: sequence of the binding domain involved in adherence of streptococci to epithelial cells. Infect. Immun. 60:3837-3844.
27. Talay, S. R., P. Valentin Weigand, K. N. Timmis, and G. S. Chhatwal. 1994. Domain structure and conserved epitopes of Sfb protein, the fibronectin-binding adhesin of Streptococcus pyogenes. Mol. Microbiol. 13:531-539.
28. Talay, S. R., A. Zock, M. Rohde, G. Molinari, M. Oggioni, G. Pozzi, C. A. Guzmán, and G. S. Chhatwal. 2000. Cooperative binding of human fibronectin to SfbI protein triggers streptococcal invasion into respiratory epithelial cells. Cell. Microbiol. 2:521-535.
29. Valentin Weigand, P., S. R. Talay, A. Kaufhold, K. N. Timmis, and G. S. Chhatwal. 1994. The fibronectin binding domain of the Sfb protein adhesin of Streptococcus pyogenes occurs in many group A streptococci and does not cross-react with heart myosin. Microb. Pathog. 17:111-120.
30. Vordermeier, H.-M., D. P. Harris, C. Moreno, M. Singh, and J. Ivanyi. 1995. The nature of the immunogen determines the specificity of antibodies and T cells to selected peptides of the 38 kDa mycobacterial antigen. Int. Immunol. 7:559-566.
31. Wang, C. W., D. J. Looney, M. L. Li, A. M. Walfield, J. Ye, B. Hosein, J. P. Tam, and F. Wong-Staal. 1991. Long-term high-titer neutralizing activity induced by octameric synthetic HIV-1 antigen. Science 254:285-288.
32. World Health Organization. 1980. Community control of rheumatic heart disease in developing countries. 1. A major public health problem. W. H. O. Chron. 34:336-345.